Citation Impact
Citing Papers
Humanized Foxp2 accelerates learning by enhancing transitions from declarative to procedural performance
2014 StandoutNobel
Anticoagulant Use in Patients with Chronic Renal Impairment
2005
Child abuse: Adolescent records vs. adult recall
1990 Standout
The neural basis of drug craving: An incentive-sensitization theory of addiction
1993 Standout
Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V)
2003
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
1996 StandoutNature
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
2018 StandoutNobel
Anatomical and physiological evidence for D1 and D2 dopamine receptor colocalization in neostriatal neurons
2000 StandoutNobel
Getting Formal with Dopamine and Reward
2002 Standout
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Foxp2 controls synaptic wiring of corticostriatal circuits and vocal communication by opposing Mef2c
2016 StandoutNobel
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Drug-Induced Liver Injury in Humans: The Case of Ximelagatran
2009
The pain of antisense: in vivo application of antisense oligonucleotides for functional genomics in pain and analgesia
2003
Stroke Prevention Using the Oral Direct Thrombin Inhibitor Ximelagatran in Patients with Non-Valvular Atrial Fibrillation
2006
The free-energy principle: a unified brain theory?
2010 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
2011 Standout
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat
1998
Dopamine Receptor Activation Is Required for Corticostriatal Spike-Timing-Dependent Plasticity
2008
The Reorienting System of the Human Brain: From Environment to Theory of Mind
2008 Standout
Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study
2008 Standout
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Functional diversity along the transverse axis of hippocampal area CA1
2014 StandoutNobel
Heparin-Induced Thrombocytopenia
2006 Standout
Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial
2007
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Differences in the clinically effective molar concentrations of four direct thrombin inhibitors explain their variable prothrombin time prolongation
2005
Widespread changes in protein synthesis induced by microRNAs
2008 StandoutNature
Prevention of Venous Thromboembolism
2004 Standout
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
The neural basis of human error processing: Reinforcement learning, dopamine, and the error-related negativity.
2002 Standout
Extensive co‐occurrence of substance P and dynorphin in striatal projection neurons: An evolutionarily conserved feature of basal ganglia organization
1990
Antithrombotic Therapy in Atrial Fibrillation
2004
Humanized Foxp2 specifically affects cortico-basal ganglia circuits
2010 StandoutNobel
Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
2005
Ximelagatran vs Low-Molecular-Weight Heparin and Warfarin for the Treatment of Deep Vein Thrombosis
2005
Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Hip Arthroplasty
2008 Standout
Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons
1995 StandoutNobel
Prevention of Venous Thromboembolism
2008 Standout
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Immunohistochemical localization of DARPP-32 in striatal projection neurons and striatal interneurons: implications for the localization of D1-like dopamine receptors on different types of striatal neurons
1991
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
P2 receptors are involved in the mediation of motivation-related behavior
2004
Drug Dependence, a Chronic Medical Illness
2000 Standout
A leu‐enkephalin depresses transmission from muscle and skin non‐nociceptors to first‐order feline spinal neurones
1998
Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat
2000
Chronic social stress, hedonism and vulnerability to obesity: Lessons from Rodents
2008
Dopamine, learning and motivation
2004 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Electrical Stimulation of the Prefrontal Cortex Increases Cholecystokinin, Glutamate, and Dopamine Release in the Nucleus Accumbens: anIn VivoMicrodialysis Study in Freely Moving Rats
1998
Oral Rivaroxaban for Symptomatic Venous Thromboembolism
2010 Standout
The Role of the Medial Frontal Cortex in Cognitive Control
2004 StandoutScience
Cutaneous Merkel cells of the rat contain both dynorphin A and vesicular monoamine transporter type 1 (VMAT1) immunoreactivity
1998
An Integrative Theory of Prefrontal Cortex Function
2001 Standout
Spinal and Supraspinal Factors in Human Muscle Fatigue
2001 Standout
Predictive Reward Signal of Dopamine Neurons
1998 Standout
Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation
2007 Standout
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Cellular and Molecular Mechanisms of Drug Dependence
1988 StandoutScience
Drug Abuse: Hedonic Homeostatic Dysregulation
1997 StandoutScience
Ximelagatran vs Warfarin for Stroke Prevention in Patients With Nonvalvular Atrial Fibrillation
2005
A Field Guide to Foldamers
2001 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Development and validation of a predictive model for chemotherapy-associated thrombosis
2008 Standout
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial
2007
Potent and nontoxic antisense oligonucleotides containing locked nucleic acids
2000
Cutaneous Merkel cells of the rat contain both dynorphin A and vesicular monoamine transporter type 1 (VMAT1) immunoreactivity
1998
Electrical stimulation of the prefrontal cortex increases cholecystokinin, glutamate, and dopamine release in the nucleus accumbens: an in vivo microdialysis study in freely moving rats.
1998
Separate Neural Systems Value Immediate and Delayed Monetary Rewards
2004 StandoutScience
Works of I Nylander being referenced
Met-enkephalin inhibits 5-hydroxytryptamine release from the rat ventral spinal cord via δ opioid receptors
1996
Levels of dynorphin peptides, substance P and CGRP in the spinal cord after subchronic administration of morphine in the rat
1991
Long-term effects of maternal separation on ethanol intake and brain opioid and dopamine receptors in male wistar rats
2003
Dopamine receptors mediate alterations in striato-nigral dynorphin and substance p pathways
1987
A comparison between microwave irradiation and decapitation: basal levels of dynorphin and enkephalin and the effect of chronic morphine treatment on dynorphin peptides
1997
Differential effects of intrastriatally infused fully and endcap phosphorothioate antisense oligonucleotides on morphology, histochemistry and prodynorphin expression in rat brain
2000
On the Origin of Extracellular Glutamate Levels Monitored in the Basal Ganglia of the Rat by In Vivo Microdialysis
1996
Direct thrombin inhibitor melagatran followed by oral ximelagatran in comparison with enoxaparin for prevention of venous thromboembolism after total hip or knee replacement
2003